1. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442–9.
2. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2002;34(3):346–53.
3. Honda H, Dubberke ER. The changing epidemiology of Clostridium difficile infection. Current opinion in gastroenterology. 2014;30(1):54–62.
4. Tattevin P, Buffet-Bataillon S, Donnio PY, Revest M, Michelet C. Clostridium difficile infections: do we know the real dimensions of the problem? Int J Antimicrob Agents. 2013;42 Suppl:36–40.
5. Jin D, Luo Y, Huang C, Cai J, Ye J, Zheng Y, Wang L, Zhao P, Liu A, Fang W, et al. Molecular Epidemiology of Clostridium difficile Infection in Hospitalized Patients in Eastern China. J Clin Microbiol. 2017;55(3):801–10.
6. Galaydick J, Xu Y, Sun L, Landon E, Weber SG, Sun D, Zhou J, Sherer R. Seek and you shall find: prevalence of Clostridium difficile in Wuhan, China. Am J Infect Control. 2015;43(3):301–2.
7. Chen YB, Gu SL, Wei ZQ, Shen P, Kong HS, Yang Q, Li LJ. Molecular epidemiology of Clostridium difficile in a tertiary hospital of China. Journal of medical microbiology. 2014;63(Pt 4):562–9.
8. Chen YB, Gu SL, Shen P, Lv T, Fang YH, Tang LL, Li LJ. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China. Journal of medical microbiology. 2018;67(1):52–9.
9. Huang H, Wu S, Chen R, Xu S, Fang H, Weintraub A, Nord CE. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China. Anaerobe. 2014;30:65–9.
10. Albarrak AA, Romana BS, Uraz S, Yousef MH, Al Juboori A, Tahan V. Clostridium difficile infection in Inflammatory Bowel Disease Patients. Endocrine, metabolic & immune disorders drug targets 2019.
11. Binion D. Clostridium difficile Infection and Inflammatory Bowel Disease. Gastroenterology hepatology. 2016;12(5):334–7.
12. Kelsen JR, Sullivan KE. Inflammatory Bowel Disease in Primary Immunodeficiencies. Curr Allergy Asthma Rep. 2017;17(8):57.
13. Tremaine WJ. Inflammatory Bowel Disease and Clostridium difficile-associated diarrhea: a growing problem. Clinical gastroenterology hepatology: the official clinical practice journal of the American Gastroenterological Association. 2007;5(3):310–1.
14. Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390(10114):2769–78.
15. LaMont JT, Trnka YM. Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease. Lancet. 1980;1(8165):381–3.
16. Maharshak N, Barzilay I, Zinger H, Hod K, Dotan I. Clostridium difficile infection in hospitalized patients with inflammatory bowel disease: Prevalence, risk factors, and prognosis. Medicine. 2018;97(5):e9772.
17. Rezapour M, Galoosian A, Liu B, Bhuket T, Wong RJ. Clostridium difficile co-infection in inflammatory bowel disease is associated with significantly increased in-hospital mortality. Eur J Gastroenterol Hepatol. 2018;30(9):1041–6.
18. Fu N, Wong T. Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Curr Infect Dis Rep. 2016;18(6):19.
19. Jen MH, Saxena S, Bottle A, Aylin P, Pollok RC. Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33(12):1322–31.
20. Sokol H, Lalande V, Landman C, Bourrier A, Nion-Larmurier I, Rajca S, Kirchgesner J, Seksik P, Cosnes J, Barbut F, et al. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study. Digestive liver disease: official journal of the Italian Society of Gastroenterology the Italian Association for the Study of the Liver. 2017;49(6):643–6.
21. Chen X, Deng J, Chen X, Wan S, Wang Y, Cao Q. High Incidence and Morbidity of Clostridium Difficile Infection Among Hospitalized Patients with Inflammatory Bowel Disease - A Prospective Observational Cohort Study. Journal of digestive diseases 2019.
22. Zhang T, Lin QY, Fei JX, Zhang Y, Lin MY, Jiang SH, Wang P, Chen Y. Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel Disease. Scientific reports. 2016;6:29791.
23. Bassetti M, Villa G, Pecori D, Arzese A, Wilcox M. Epidemiology, diagnosis and treatment of Clostridium difficile infection. Expert review of anti-infective therapy. 2012;10(12):1405–23.
24. Rodemann JF, Dubberke ER, Reske KA, Seo DH, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clinical gastroenterology hepatology: the official clinical practice journal of the American Gastroenterological Association. 2007;5(3):339–44.
25. Ananthakrishnan AN, Binion DG. Impact of Clostridium difficile on inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2010;4(5):589–600.
26. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology infection: the official publication of the European Society of Clinical Microbiology Infectious Diseases. 2012;18(3):268–81.
27. Hourigan SK, Sears CL, Oliva-Hemker M. Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22(4):1020–5.
28. Hourigan SK, Oliva-Hemker M, Hutfless S. The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease. Digestive diseases sciences. 2014;59(9):2222–7.
29. Enoch DA, Butler MJ, Pai S, Aliyu SH, Karas JA. Clostridium difficile in children: colonisation and disease. J Infect. 2011;63(2):105–13.
30. Borali E, De Giacomo C. Clostridium Difficile Infection in Children: A Review. J Pediatr Gastroenterol Nutr. 2016;63(6):e130–40.
31. Tian TT, Zhao JH, Yang J, Qiang CX, Li ZR, Chen J, Xu KY, Ciu QQ, Li RX. Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment. PloS one. 2016;11(3):e0151964.
32. Liao F, Li W, Gu W, Zhang W, Liu X, Fu X, Xu W, Wu Y, Lu J. A retrospective study of community-acquired Clostridium difficile infection in southwest China. Scientific reports. 2018;8(1):3992.
33. McFarland LV, Ozen M, Dinleyici EC, Goh S. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World journal of gastroenterology. 2016;22(11):3078–104.
34. Terhes G, Brazier JS, Urban E, Soki J, Nagy E. Distribution of Clostridium difficile PCR ribotypes in regions of Hungary. Journal of medical microbiology. 2006;55(Pt 3):279–82.
35. Zhou FF, Wu S, Klena JD, Huang HH. Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China. European journal of clinical microbiology infectious diseases: official publication of the European Society of Clinical Microbiology. 2014;33(10):1773–9.
36. Adams DJ, Eberly MD, Rajnik M, Nylund CM. Risk Factors for Community-Associated Clostridium difficile Infection in Children. J Pediatr. 2017;186:105–9.